Intas Pharmaceuticals Limited — Aspirin Exporter Profile
Indian Pharmaceutical Exporter · #13 for Aspirin · $1.2M export value · DGFT Verified
Intas Pharmaceuticals Limited is the #13 Indian exporter of Aspirin with $1.2M in export value and 69 verified shipments. Intas Pharmaceuticals Limited holds a 3.1% market share in Aspirin exports across 4 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.
Intas Pharmaceuticals Limited — Aspirin Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Limited Export Aspirin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $993.3K | 59 | 82.8% |
| NETHERLANDS | $166.8K | 7 | 13.9% |
| UNITED KINGDOM | $24.1K | 3 | 2.0% |
| CONGO | $16.0K | 1 | 1.3% |
Intas Pharmaceuticals Limited exports Aspirin to 4 countries. The largest destination is SOUTH AFRICA accounting for 82.8% of Intas Pharmaceuticals Limited's Aspirin shipments, followed by NETHERLANDS (13.9%) and UNITED KINGDOM (2.0%). These destinations reflect Intas Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Aspirin from Intas Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ACINO PHARMA (PTY) LTD | SOUTH AFRICA | $554.8K | 46 |
| ACINO PHARMA PTY LTD | SOUTH AFRICA | $233.9K | 5 |
| TO THE ORDER., | SOUTH AFRICA | $154.6K | 7 |
| ACCORD HEALTHCARE B V | NETHERLANDS | $108.3K | 4 |
| XXCORXXHEAXXHCAXX B XX | NETHERLANDS | $58.5K | 3 |
| ACINO PHARMA (PTY) LIMITED | SOUTH AFRICA | $50.0K | 1 |
| ACCORD UK | UNITED KINGDOM | $24.1K | 3 |
| UNION DE QUERIR | CONGO | $16.0K | 1 |
Intas Pharmaceuticals Limited supplies Aspirin to 8 buyers globally. The largest buyer is ACINO PHARMA (PTY) LTD (SOUTH AFRICA), followed by ACINO PHARMA PTY LTD (SOUTH AFRICA) and TO THE ORDER., (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Aspirin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?
India exported $23.7M worth of Aspirin through 3,422 shipments from 327 suppliers to 121 countries, serving 805 buyers globally. Intas Pharmaceuticals Limited contributes $1.2M to this total, accounting for 3.1% of India's Aspirin exports. Intas Pharmaceuticals Limited ships Aspirin to 4 countries through 8 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Aspirin Exports?
Intas Pharmaceuticals Limited's average Aspirin shipment value is $17.2K per consignment, based on 69 shipments totaling $1.2M. The largest destination is SOUTH AFRICA (82.8% of Intas Pharmaceuticals Limited's Aspirin exports).
How Does Intas Pharmaceuticals Limited Compare to Other Indian Aspirin Exporters?
Intas Pharmaceuticals Limited ranks #13 among 327 Indian Aspirin exporters with a 3.1% market share. The top 3 exporters are RECKITT BENCKISER (INDIA) PRIVATE LIMITED ($3.8M), CIPLA LIMITED ($2.5M), RECKITT BENCKISER INDIA PRIVATE LIMITED ($2.2M). Intas Pharmaceuticals Limited processed 69 shipments to 4 destination countries.
What Aspirin Formulations Does Intas Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHR DRUGS&MEDI ECOTRIN 81MG 3X10T G1(AMDI-SA EACH ENTERIC COATED TABLET CONTAINSASPIRIN PH. EUR. 81MG | $123.7K | 4 |
| PHR DRUGS MEDI ECOTRIN 81MG 3X10T G1 AMDI SA EACH ENTERIC COATED TABLET CONTAINSASPIRIN PH EUR 81MG | $100.0K | 2 |
| NUPRINASPIRIN 75MG 2X14T ACO-IE | $92.4K | 3 |
| PHARMA DRUG MED ECOTRIN 81MG 10X10TG1 AMDI SA EACH ENTERIC COATED TABLET CONTAINS ASPIRIN PH EUR 81MG | $83.9K | 2 |
| PHARMA DRUGS AND MEDICINE-ECOTRIN 81MG 3X10T G1(AMDI-SA EACH ENTERIC COATED TABLET CONTAINS:ASPIRIN PH. EUR..81MG-AS PER | $67.2K | 4 |
| PHARMA DRUGS AND MEDI ECOTRIN 81MG 10X10TG1(AMDI-SA) EACH ENTERIC COATED TABLETCONTAINS: ASPIRIN PH. EUR.81MG | $54.0K | 9 |
| PHARMA DRUGS AND MEDI ECOTRIN 81MG 10X10TG1(AMDI-SA) EACH ENTERIC COATED TABLETCONTAINS:ASPIRIN PH. EUR.81MG | $51.5K | 4 |
| PHARMA DRUG MED ECOTRIN 81MG 10X10TG1 AMDI SA EACH ENTERIC COATED TABLET CONTAINS ASPIRIN PH EUR 81MG AS PER INV | $50.0K | 1 |
| PHARMA DRUGS AND MEDI ECOTRIN 81MG 10X10TG1(AMDI-SA) EACH ENTERIC COATED TABLETCONTAINS: ASPIRIN PH.EUR.81MG | $50.0K | 1 |
| PHARMA DRUGS AND MEDICINE-ECOTRIN 81MG 3X10TG1(AMDI-SA EACH ENTERIC COATEDTABLETCONTAINS:ASPIRIN PH.EURQTY.113532X3X10T | $50.0K | 1 |
Intas Pharmaceuticals Limited exports 30 distinct Aspirin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHR DRUGS&MEDI ECOTRIN 81MG 3X10T G1(AMDI-SA EACH ENTERIC CO with 4 shipments worth $123.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Aspirin to Key Markets
What Intas Pharmaceuticals Limited must comply with to export Aspirin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Limited Compare to Nearest Aspirin Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | AJANTA PHARMA LIMITED | $1.2M | 28 | 5 | $44.2K |
| 12 | MEDREICH LIMITED | $1.2M | 141 | 4 | $8.5K |
| 13 | INTAS PHARMACEUTICALS LIMITED ★ | $1.2M | 69 | 4 | $17.2K |
| 9 | SRI KRISHNA PHARMACEUTICALS LIMITED | $1.1M | 22 | 4 | $50.0K |
| 14 | GRANULES INDIA LIMITED | $1.1M | 57 | 1 | $19.0K |
Intas Pharmaceuticals Limited ranks #13 among 327 Indian Aspirin exporters. Average shipment value of $17.2K compared to the market average of $72.4K. The closest competitors by value are AJANTA PHARMA LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Aspirin Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 426 | 12.4% |
| SAHAR AIR | 424 | 12.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 373 | 10.9% |
| NHAVA SHEVA SEA (INNSA1) | 348 | 10.2% |
| JNPT/ NHAVA SHEVA SEA | 159 | 4.6% |
| JNPT | 124 | 3.6% |
| Bombay Air | 107 | 3.1% |
| BANGALORE ICD (INWFD6) | 104 | 3.0% |
Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Aspirin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.
Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.
About Intas Pharmaceuticals Limited
Intas Pharmaceuticals Limited exports 75 products worth $372.3M. Beyond Aspirin, top products include Ras, Mycophenolate, Tacrolimus, Apixaban, Ezetimibe. View the complete Intas Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Aspirin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Aspirin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 70 individual customs records matching Intas Pharmaceuticals Limited exporting Aspirin, covering 30 formulations to 4 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Aspirin Export Data from Intas Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Limited's Aspirin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Limited
Full Company Profile →
75 products · $372.3M total trade · 19 categories
Aspirin Stats
Company Overview
Top Products by Intas Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Aspirin. For current shipment-level data, contact TransData Nexus.